Phreesia (NYSE:PHR) Shares Down 8.4% – What’s Next?

Shares of Phreesia, Inc. (NYSE:PHR) were down 8.4% on Thursday . The company traded as low as $10.17 and last traded at $10.20. 161,728 shares traded hands during trading, a decline of 90% from the average daily volume of 1,614,601 shares. The stock had previously closed at $11.14.

Analyst Ratings Changes

Several analysts have recently weighed in on PHR shares. Wall Street Zen upgraded shares of Phreesia from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Citigroup reaffirmed a “market perform” rating on shares of Phreesia in a research report on Friday, May 29th. Weiss Ratings upgraded shares of Phreesia from a “sell (d)” rating to a “sell (d+)” rating in a research note on Monday, July 20th. DA Davidson reissued a “buy” rating and issued a $14.00 price target on shares of Phreesia in a research report on Thursday, May 28th. Finally, Wells Fargo & Company restated an “equal weight” rating and issued a $9.00 price objective (down from $15.00) on shares of Phreesia in a research note on Wednesday, May 20th. Nine research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $16.65.

Phreesia Stock Performance

The company has a market cap of $662.97 million, a PE ratio of 71.51 and a beta of 0.87. The stock has a 50 day simple moving average of $10.04 and a two-hundred day simple moving average of $10.92. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.76 and a quick ratio of 1.76.

Phreesia (NYSE:PHR) last announced its earnings results on Wednesday, May 27th. The company reported $0.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $0.03. The business had revenue of $130.94 million for the quarter, compared to analyst estimates of $130.08 million. Phreesia had a net margin of 1.85% and a return on equity of 5.13%. The company’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period last year, the firm posted ($0.07) earnings per share. Equities analysts predict that Phreesia, Inc. will post 0.39 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of PHR. Pale Fire Capital SE acquired a new position in Phreesia in the first quarter valued at $72,481,000. Vanguard Group Inc. grew its holdings in shares of Phreesia by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 5,744,326 shares of the company’s stock worth $97,194,000 after buying an additional 39,540 shares during the last quarter. Granahan Investment Management LLC grew its holdings in shares of Phreesia by 73.8% during the fourth quarter. Granahan Investment Management LLC now owns 2,399,613 shares of the company’s stock worth $40,601,000 after buying an additional 1,018,987 shares during the last quarter. Franklin Resources Inc. increased its position in Phreesia by 28.8% in the 4th quarter. Franklin Resources Inc. now owns 2,000,082 shares of the company’s stock valued at $33,841,000 after acquiring an additional 446,890 shares during the period. Finally, Nuveen LLC increased its position in Phreesia by 12.7% in the 4th quarter. Nuveen LLC now owns 1,875,725 shares of the company’s stock valued at $31,737,000 after acquiring an additional 211,262 shares during the period. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.